This review focuses on 3 allergic disorders of persons coming up against venerable age: asthma, allergic rhinitis, and atopic dermatitis. The prevalence of allergic diseases in the elderly ranges from 5 to 10% and appears to be rising. A gradual decline in immune function, termed immunosenescence, and age-related changes in tissue structure influence the development of these disorders. Common complications are comorbidities, polypharmacy, and adverse effects of drugs. The elderly have difficulty mounting protective immune responses against newly encountered antigens. The integrity of epithelial barriers is compromised, leading to a chronic, subclinical inflammatory state and an enhanced Th2 (allergic) immune response. Undiagnosed asthma is frequent in elderly persons (about 8%) and still more commonplace in those with respiratory symptoms. Poorly controlled asthma in the elderly undermines their functional status and leads to a loss of autonomy and social isolation that may delay seeking medical services. Aggravation of allergic rhinitis coincides with exacerbation of asthma, whereas treatment of nasal inflammation improves control of the asthma. Atopic dermatitis is a chronically relapsing inflammatory skin disease often associated with respiratory allergy.

Keywords:
Elderly, Allergic disorders, Asthma, Allergic rhinitis, Allergic dermatitis, Immunosenescence, Inflammation, Comorbidity
1.
Mathur SK: Allergy and asthma in the elderly. Semin Respir Crit Care Med 2010;31:587-595.
2.
Cambier J: Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev 2005;205:5-6.
3.
Hannoun C, Megas F, Piercy J: Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004;103:133-138.
4.
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S: Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92-105.
5.
Gunin AG, Kornilova NK, Vasilieva OV, Petrov VV: Age-related changes in proliferation, the numbers of mast cells, eosinophils, and CD45-positive cells in human dermis. J Gerontol A Biol Sci Med Sci 2011;66:385-392.
6.
Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, Wherry EJ, Jessup HK, Siegel LA, Kambayashi T, Dudek EC, Kubo M, Cianferoni A, Spergel JM, Ziegler SF, Comeau MR, Artis D: TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011;477:229-233.
7.
Diesner SC, Untersmayr E, Pietschmann P, Jensen-Jarolim E: Food allergy: only a pediatric disease? Gerontology 2011;57:28-32.
8.
Untersmayr E, Diesner SC, Bramswig KH, Knittelfelder R, Bakos N, Gundacker C, Lukschal A, Wallmann J, Szalai K, Pali-Scholl I, Boltz-Nitulescu G, Scheiner O, Duschl A, Jensen-Jarolim E: Characterization of intrinsic and extrinsic risk factors for celery allergy in immunosenescence. Mech Ageing Dev 2008;129:120-128.
9.
Barnes PJ: Pathophysiology of allergic inflammation. Immunol Rev 2011;242:31-50.
10.
Boguniewicz M, Leung DY: Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011;242:233-246.
11.
Cardona V, Guilarte M, Luengo O, Labrador-Horrillo M, Sala-Cunill A, Garriga T: Allergic diseases in the elderly. Clin Transl Allergy 2011;1:11.
12.
Sherman R, Milgrom H: Asthma and activities of daily living. Clin Rev Allergy Immunol 2005;29:159-164.
13.
Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ: National surveillance for asthma - United States, 1980-2004. MMWR Surveill Summ 2007;56:1-54.
14.
Hanania NA, King MJ, Braman SS, Saltoun C, Wise RA, Enright P, Falsey AR, Mathur SK, Ramsdell JW, Rogers L, Stempel DA, Lima JJ, Fish JE, Wilson SR, Boyd C, Patel KV, Irvin CG, Yawn BP, Halm EA, Wasserman SI, Sands MF, Ershler WB, Ledford DK: Asthma in the elderly: current understanding and future research needs - a report of a National Institute on Aging (NIA) Workshop. J Allergy Clin Immunol 2011;128:S4-S24.
15.
Enright PL: The diagnosis and management of asthma is much tougher in older patients. Curr Opin Allergy Clin Immunol 2002;2:175-181.
16.
Stupka E, deShazo R: Asthma in seniors. 1. Evidence for underdiagnosis, undertreatment, and increasing morbidity and mortality. Am J Med 2009;122:6-11.
17.
Wood RP 2nd, Milgrom H: Vocal cord dysfunction. J Allergy Clin Immunol 1996;98:481-485.
18.
Busse PJ, Kilaru K: Complexities of diagnosis and treatment of allergic respiratory disease in the elderly. Drugs Aging 2009;26:1-22.
19.
Cardenas-Valladolid J, Martin-Madrazo C, Salinero-Fort MA, Carrillo de-Santa Pau E, Abanades-Herranz JC, de Burgos-Lunar C: Prevalence of adherence to treatment in homebound elderly people in primary health care: a descriptive, cross-sectional, multicentre study. Drugs Aging 2010;27:641-651.
20.
Janssens JP, Pache JC, Nicod LP: Physiological changes in respiratory function associated with ageing. Eur Respir J 1999;13:197-205.
21.
Tsai CL, Lee WY, Hanania NA, Camargo CA Jr: Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol 2012;129:1252-1258.
22.
Global Strategy for Asthma Management and Prevention 2011 (update). www.ginasthma.org.
23.
National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.
24.
Milgrom H, Curran-Everett D: Unrecognized nonadherence masquerades as drug resistance. Curr Opin Allergy Clin Immunol 2012;12:219-220.
25.
Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R: External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007; 62:219-223.
26.
Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC: Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-1293.
27.
Nagasaki T, Matsumoto H: Influences of smoking and aging on allergic airway inflammation in asthma. Allergol Int DOI: 10.2332_allergolint.12-RA-0523.
28.
Nie H, Zhang G, Liu M, Ding X, Huang Y, Hu S: Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma. Respir Med 2013;107:347-354.
29.
Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM: The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15-26.
30.
Chowdhury BA, Dal Pan G: The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010;362:1169-1171.
31.
Chowdhury BA, Seymour SM, Levenson MS: Assessing the safety of adding labas to inhaled corticosteroids for treating asthma. N Engl J Med 2011;364:2473-2475.
32.
Nelson H, Bonuccelli C, Radner F, Ottosson A, Carroll KJ, Andersson TL, LaForce C: Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trials. J Allergy Clin Immunol 2010;125:390-396.e398.
33.
Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB: Long-acting β2-agonist step-off in patients with controlled asthma. Arch Intern Med 2012;172:1365-1375.
34.
Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ: Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 study group. N Engl J Med 1999;341:1966-1973.
35.
Verma P, Randhawa I, Klaustermeyer WB: Clinical efficacy of omalizumab in an elderly veteran population with severe asthma. Allergy Asthma Proc 2011;32:346-350.
36.
Campbell JD, Spackman DE, Sullivan SD: The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy 2010;65:1141-1148.
37.
Corren J: Cytokine inhibition in severe asthma: current knowledge and future directions. Curr Opin Pulm Med 2011;17:29-33.
38.
Melani AS: Management of asthma in the elderly patient. Clin Interv Aging 2013;8:913-922.
39.
Marogna M, Bruno ME, Massolo A, Falagiani P: Sublingual immunotherapy for allergic respiratory disease in elderly patients: a retrospective study. Eur Ann Allergy Clin Immunol 2008;40:22-29.
40.
Pinto JM, Jeswani S: Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 2010;6:10.
41.
Antonicelli L, Micucci C, Voltolini S, Feliziani V, Senna GE, Di Blasi P, Visona G, De Marco R, Bonifazi F: Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007;37:954-960.
42.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(suppl 86):8-160.
43.
Slavin RG: Treating rhinitis in the older population: special considerations. Allergy Asthma Clin Immunol 2009;5:9.
44.
Bozek A, Ignasiak B, Filipowska B, Jarzab J: House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy 2013;43:242-248.
45.
Bieber T, Novak N: Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 2009;9:291-294.
46.
Novak N, Leung DY: Advances in atopic dermatitis. Curr Opin Immunol 2011;23:778-783.
47.
Bieber T: Atopic dermatitis. N Engl J Med 2008;358:1483-1494.
48.
de Benedetto A, Kubo A, Beck LA: Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol 2012;132:949-963.
49.
National Food Institute, Technical University of Denmark: Food Allergy Information. http://www.foodallergens.info/Allergenic_Foods/Veg.html.
50.
Novak N: An update on the role of human dendritic cells in patients with atopic dermatitis. J Allergy Clin Immunol 2012;129:879-886.
51.
Novak N, Simon D: Atopic dermatitis - from new pathophysiologic insights to individualized therapy. Allergy 2011;66:830-839.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.